Versione italiana
icar2019.it
CROI-ICAR Awards

CROI-ICAR Awards 2019

As tradition, the Young Italian Investigators will be awarded during the two next main Conferences - CROI and ICAR:

Seattle March 6th, 2019
CROI Affiliated Event for Young Investigators
Sheraton Grand Seattle – h. 18.30-20.30

Only 11 abstracts will be presented during the session. The selection will be made by a International Jury on the basis of quality, originality and scientific relevance.

Milan, June 5th, 2019
During the Conference Opening Session
Università degli Studi di Milano – h. 17.30-20.30

Selected Italian Investigators and Mentors

INI-resistance dynamics from 2007 to 2017 in Italian clinical isolates
D. Armenia Tor Vergata University of Rome – MENTORS F. Ceccherini-Silberstein, M. Santoro

GSS of NRTI-backbone predicts time to virological failure of INI-based regimens
A. Borghetti Cattolica del Sacro Cuore University of Rome – MENTOR S. Di Giambenedetto

Quantification of CD64: a predictive biomarker for progression to active tuberculosis
C. Ceriani ASST Ovest Milanese, Legnano (MI) – MENTOR P. Clerici

Subclinical tubular impairment is common in ART-treated HIV+ patients in Uganda
C. Costa Amedeo di Savoia Hospital, Turin – MENTOR A. Calcagno

Evolution and reversibility of renal function after switch from TDF to TAF regimens
R. Gagliardini National Institute for Infectious Diseases “L. Spallanzani”, Rome – MENTOR A. Antinori

Impact of HBCAB+ on advanced liver fibrosis development in HIV-HBV infected patients
V. Malagnino Tor Vergata University of Rome – MENTOR L. Sarmati

Metabolomic profiling of HIV patients with and without HIV-associated dementia
A. Mastrangelo Vita-Salute San Raffaele University, Milan – MENTOR P. Cinque

Extracellular vesicle–associated cytokines in HIV-infected human ex vivo tonsils
V. Mercurio University of Milan – MENTORS M. Biasin, L. Margolis

HCV late relapse in patients with directly acting antiviral–related SVR 12
C. Minichini Luigi Vanvitelli, University of Naples – MENTOR N. Coppola

Effectiveness of single- vs multiple-tablet regimens as 1st-line ART in ICONA cohort
A. Mondi National Institute for Infectious Diseases “L. Spallanzani”, Rome – MENTOR A. Antinori

Modulation of gut microbiota improves mucosal permeability in HIV+ patients
C. Pinacchio Sapienza University of Rome – MENTOR G. d’Ettorre

Interferon-free regimens improve renal function in patients with chronic Hepatitis C
F. Portunato Luigi Vanvitelli, University of Naples – MENTOR N. Coppola

Genotypic and phenotypic susceptibility to fostemsavir in multidrug-resistant HIV-1
F. Saladini University of Siena – MENTOR M. Zazzi

In vitro activity of DTG/BIC/E/CAB on first-generation INSTI-resistant HIV-1
F. Saladini University of Siena – MENTOR M. Zazzi

ERAP2 administration reduces in vitro PBMC susceptibility to HIV-1-infection
I. Saulle University of Milan – MENTOR M. Biasin

Time to undetectable viral load achievement after ART start and risk of mortality
V. Spagnuolo Vita-Salute San Raffaele University, Milan – MENTOR A. Castagna

Increased SAMHD1 correlates with ISGs in HIV-1–infected patients
M. Statzu Sapienza University of Rome – MENTOR C. Scagnolari

Alzheimer’s dementia cerebrospinal fluid biomarkers in HIV-positive patients on cART
M. Trunfio University of Turin – MENTOR A. Calcagno

Relapse of symptomatic CSF HIV escape upon previously optimized cART regimen changes
F. Turrini IRCCS San Raffaele Hospital, Milan – MENTOR P. Cinque

Low performance of the oraquick HCV rapid antibody test in HIV/HCV-infected people
S. Vita S.M. Goretti Hospital, Latina – MENTOR M. Lichtner

INTERNATIONAL JURY

  • Jose Alcami University of Madrid Carlos III
  • Dan Barouch BIDMC, Harvard Medical School, Boston
  • Ann Chahroudi Emory University, Atlanta
  • Daniel Douek Vaccine Research Center, NIH, Bethesda
  • Marie-Lise Gougeon Institute Pasteur, Paris
  • Paul Johnson Yerkes Primate Research Center, Atlanta
  • Nichole Klatt University of Miami
  • Mathias Lichterfeld - MGH, Harvard Medical School, Boston
  • David Margolis University of North Carolina
  • Douglas Richman University of California San Diego
×